Cargando…
A case of severe encephalitis while on PD-1 immunotherapy for recurrent clear cell ovarian cancer
Recurrent clear cell ovarian carcinoma is a difficult to treat condition and early trial data has suggested a possible role for immune checkpoint inhibitors. Nivolumab is an anti-PD-1 immunotherapy that has been used in this setting. While immune related toxicity of these agents has been well descri...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003404/ https://www.ncbi.nlm.nih.gov/pubmed/29915799 http://dx.doi.org/10.1016/j.gore.2018.03.007 |